Edition:
United Kingdom

BTG PLC (BTG.L)

BTG.L on London Stock Exchange

542.00GBp
4:51pm BST
Change (% chg)

22.00 (+4.23%)
Prev Close
520.00
Open
535.00
Day's High
543.50
Day's Low
521.00
Volume
1,668,312
Avg. Vol
829,567
52-wk High
784.00
52-wk Low
482.40

Select another date:

Tue, May 15 2018

BRIEF-BTG full-year operating profit up 18 pct

* ADJUSTED BASIC EPS 1 32.9P UP 42 PERCENT Source text for Eikon: Further company coverage: (Reporting By London Bureau)

U.S. court invalidates Johnson & Johnson cancer drug patent, hitting UK's BTG

NEW YORK A U.S. administrative court invalidated a Johnson & Johnson patent on its blockbuster prostate cancer drug Zytiga, bringing rivals closer to selling generic versions and hitting shares in its British partner BTG Plc .

U.S. court invalidates J&J cancer drug patent, hitting UK's BTG

NEW YORK A U.S. administrative court invalidated a Johnson & Johnson patent on its blockbuster prostate cancer drug Zytiga, bringing rivals closer to selling generic versions and hitting shares in its British partner BTG Plc .

UPDATE 1-U.S. court invalidates J&J cancer drug patent, hitting UK's BTG

NEW YORK, Jan 18 A U.S. administrative court invalidated a Johnson & Johnson patent on its blockbuster prostate cancer drug Zytiga, bringing rivals closer to selling generic versions and hitting shares in its British partner BTG Plc.

Select another date: